“34. Article 3 can in principle apply where a Contracting State proposes to extradite a person to another state, whether or not that other state is itself a party to the ECHR. As it happens France is, like the United Kingdom, a party to the ECHR. 35. There must be substantial grounds for believing that, if extradited, the Appellant faces a real risk of being subjected to inhuman or degrading treatment. 36. Once such evidence has been adduced by the Appellant it is for the requesting state to dispel any doubts about it: see Saadi v Italy(2009) 49 EHRR 30 , at paras 129 and 140. 37. There is a presumption that parties to the ECHR, such as France, are willing and able to fulfil their obligations, in the absence of, “clear, cogent and compelling” evidence to the contrary. However, that presumption can be rebutted where that evidence comes from an internationally recognised source or is specific to an individual. 38. There may also be a duty on the Court in this jurisdiction to request further information from the state concerned where this is necessary to dispel any doubts. 39. In the context of prison overcrowding, there will be a strong presumption of a breach of Article 3 if any of the following criteria are absent: (1) a private sleeping place within a prison cell; (2) at least 3m 2 of floor space per prisoner; and (3) an overall surface area of the cell which is such as to allow the detainees to move freely between the furniture items. 40. Where a detainee is allocated between 3 and 4m 2 of personal space, a violation of Article 3 will be found if there are other aspects of inappropriate physical conditions: in particular, regard will be had to access to outdoor exercise; natural light or air; availability of ventilation; adequacy of room temperature; access to private toilet facilities; and compliance with basic sanitary and hygiene requirements.”
“In Aranyosi the CJEU decided that the consequence of the execution of an EAW must not be that the requested person will, if returned, suffer inhuman or degrading treatment. At [88]-[89], [91]-[92], [95] and [98] the CJEU set out the procedure that must be followed where the judicial authority of a member state is in possession of evidence of a real risk of inhuman or degrading treatment of individuals detained in the state that has issued the EAW. Stage 1 of the procedure involves determining whether there is such a risk by assessing objective, reliable, specific, and properly updated evidence. … A finding of such a risk cannot lead, in itself, to a refusal to execute the EAW. Where such a risk is identified, the court is required to proceed to stage 2. Stage 2 requires the executing judicial authority to make a specific assessment of whether there are substantial grounds to believe that the individual concerned will be exposed to that risk. To that end it must request the issuing authority to provide as a matter of urgency all necessary supplementary information on the conditions in which it is envisaged that the individual concerned will be detained. Stage 3 deals with the position after the information is provided. If in the light of that, and of any other available information, the executing authority finds that, for the individual concerned, there is a real risk of inhuman or degrading treatment, execution of the warrant must be postponed but cannot be abandoned.”
“… I assure you that European prison standards, as set out inArticle 3 of the Convention for the Protection of Human Rights and Fundamental Freedoms, the Council of Europe’s European prison rules and case law of the European courts are complied with the short stay prisons of Fresnes and Fleury-Merogis, where the majority of people handed over [from] the UK on EAWs are expected to be imprisoned for the first few days on French soil.”
“In my opinion, the conditions of detention in the women’s sections of Fleury-Merogis and Fresnes prisons clearly constitute inhuman and degrading treatment, particularly in light of the recurrent over-crowding of these prisons, the limited space allocated to each detainee and the general degraded state of these prisons.”
“He does no more than summarise and evaluate public source material”
“particulars of the circumstances in which the person is alleged to have committed the offence, including the conduct alleged to constitute the offence, the time and place at which he is alleged to have committed the offence and any provision of the law of the category 1 territory under which the conduct is alleged to constitute an offence.”
“28. I am satisfied that sufficient particulars of the offences and the RP’s role are provided: (a) Details are provided of the nature of the criminal activity - The product[s] sold. - That they were marketed as medical products. - The products were not properly authorised as medicinal products. - Details of the manufacture of the products. - The companies used to market the products. - That the products were sold on the internet. - The collection of payment by the named companies. - That the products were packed in France. - The distribution of the products. - Packages were mislabelled to mislead customs about the contents. - The number of parcels sold and the value of those sales. (b) Details are provided of the amount of payment the RP received from two of the companies used to handle the sales of the products. (c) The RP’s role is detailed as the daily management on French soil of the fraudulent activities. (d) At the RP’s French home documentation, including accounting books for the business, were found. 29. There is no requirement for the JA to set out in detail the mens rea for the offences and how this role is proved in relation to the RP. The EAW and FI [Further Information] 04.04.18 read as a whole make clear the RP’s role in selling products that were falsely marketed as medicinal products. The clear inference can be drawn that it is alleged that the RP was aware that these were not properly authorised medicinal products. Whether the mens rea can be proved will be a matter for trial in France.”
“6. In terms of the conduct alleged against Ms Thyer are you able to explain to us precisely her involvement in the criminal acts as opposed to Mr Noakes, her co-accused? In December 2005, the United Kingdom (Medicines and Healthcare Products Regulatory Agency – MHRA) informed France (Central Office for Fight against Attacks towards the Environment and Public Health – OCLAESP) that two products GC protein derived macrophage activating factor and G Oleanolic acid were being manufactured in France and placed on the market via the Internet and sold throughout the world, without being granted a marketing authorisation (French AMM). These products, qualified as medicinal products by presentation, are known as Gcmaf and Goelic and were deceitfully attributed miraculous properties and presented as preventative and curative treatments against human diseases such as cancer, autism, AIDS, Lyme disease, herpes, multiple sclerosis, psoriasis, Alzheimer or Parkinson. Several death cases related to the injection of these products were reported across Europe. EUROJUST made it possible to bring together several investigation services and judges throughout Europe. MHRA explained that it had dismantled a network of fraudulent marketing of these products established in the United Kingdom by a British businessman named Mr David NOAKES, residing in the Channel Islands. His manufacturing workshops having been dismantled in the UK, he set them up again in France and in several other European states. The investigations conducted confirmed these facts and established that David NOAKES was leading a ‘network’ responsible for manufacturing, packaging, and selling these unauthorised products worldwide. It was further demonstrated that he relied on different companies, namely located in the Netherlands in the city of Bunnik, and managed by his relatives. Thus, the companies HEALTH SUPPLEMENTS and DUURZAAM GEZOND PRODUCTION (trade name: EU SUPPLEMENTS) were in charge of handling online orders, processing them, and collecting payments in Guernsey. Financial flows were also revealed between these companies and the identified persons on French soil in charge of shipping the orders placed with these companies. This made it possible to locate a packaging site in France as well as a manufacturing workshop set [up] by the accused following the dismantling of the same activities in Great Britain. It was revealed that David Noakes himself took care of delivering goods by air using his private jet plane registered under the name 2LOVE at the airport of CHERBOURG MAUPERTUIS. He flew his aircraft himself, most often from Guernsey, where he owns a sumptuous residence. By analysing the content of telephone taps, it was revealed that David NOAKES had many accomplices in Guernsey, where his company was headquartered, in charge of managing orders and financial flows. A financial investigation is ongoing in Guernsey. The daily management of the activities established by David Noakes on French soil was entrusted by Mr Noakes to his companion, Ms Lynda THYER, whose house was searched and where the accounting books of these activities as well as material related to these facts were found: and to Mr David HALSALL, the latter being in charge of manufacturing, packaging, storing, and shipping the products. During an operation conducted on the instructions of the judge in February 20, 2017 in the region of Cherbourg, the following elements were discovered and seized: cash in 10 different currencies, 2 silver bars, 2 jaguar vehicles, a storage room, clandestine manufacturing laboratory, a stock of 7,000 vials ready to be shipped – with an estimated resale value of 3,150,000 Euros (7,000 vials at 450 Euros each), as well as many documents (invoices, records, manufacturing memorandum…) Over the last 18 months, investigators identified over 5,400 parcels containing products sold either as an injectable solution or administered sublingually, shipped from France to around 50 different countries. Ms THYER appears to be the person in charge of the daily management on French soil of the fraudulent activities set up by David NOAKES. In December 2005, the United Kingdom (Medicines and Healthcare Products Regulatory Agency – MHRA) informed France (Central Office for Fight against Attacks towards the Environment and Public Health – OCLAESP) that two products GC protein derived macrophage activating factor and G Oleanolic acid were being manufactured in France and placed on the market via the Internet and sold throughout the world, without being granted a marketing authorisation (French AMM). These products, qualified as medicinal products by presentation, are known as Gcmaf and Goelic and were deceitfully attributed miraculous properties and presented as preventative and curative treatments against human diseases such as cancer, autism, AIDS, Lyme disease, herpes, multiple sclerosis, psoriasis, Alzheimer or Parkinson. Several death cases related to the injection of these products were reported across Europe. EUROJUST made it possible to bring together several investigation services and judges throughout Europe. MHRA explained that it had dismantled a network of fraudulent marketing of these products established in the United Kingdom by a British businessman named Mr David NOAKES, residing in the Channel Islands. His manufacturing workshops having been dismantled in the UK, he set them up again in France and in several other European states. The investigations conducted confirmed these facts and established that David NOAKES was leading a ‘network’ responsible for manufacturing, packaging, and selling these unauthorised products worldwide. It was further demonstrated that he relied on different companies, namely located in the Netherlands in the city of Bunnik, and managed by his relatives. Over the last 18 months, investigators identified over 5,400 parcels containing products sold either as an injectable solution or administered sublingually, shipped from France to around 50 different countries. 7. If so please can you tell me what level or degree of involvement she had in the criminal conduct of Mr Noakes in respect of all 9 offences Ms THYER is identified as the co-author for all the offences listed in the arrest warrant.”
“31. Where a warrant contains a number of foreign offences the judge is not concerned with the ingredients of the foreign offences… He is simply concerned, per the requirements of sections 64 and 65, to ensure that the minimum punishability threshold is satisfied for each offence or, where the person has been sentenced, that a total sentence of at least 4 months’ imprisonment has been imposed for the offences: … 32. For the purposes of sections 2 and 10, the judge’s focus should be, instead, on the conduct which is said to constitute the offence. The judge should consider the warrant and identify what the episodes of conduct are which are said to constitute the foreign offences. There may be one episode of conduct in respect of the foreign offence, or more than one. Then, the judge should consider in respect of each episode of conduct, whether the particulars required by section 2(4)(c) or section 2(6)(b) have been provided. If not, then it is open to the judge in an appropriate case to seek further information from the issuing judicial authority. … 33. Having done that then, as required by section 10(2), the judge should next ask whether each episode of conduct said to constitute the foreign offence (or each of them, if there is more than one foreign offence) is an extradition offence as defined in sections 64 and/or section 65, as appropriate. … 36. The judge will be assisted in this process if those representing the issuing judicial authority at the extradition hearing revert to the practice which, until recent times, was almost invariably followed of drafting English ‘charges’ as a means of identifying the equivalent English offences for the purposes of the ducal criminality exercise. 37. The practice under theExtradition Act 1989 was for those representing the requesting state to supply a list of the English offences which it alleged would be constituted by the conduct in the extradition request if it had been committed in England in equivalent circumstances… … 41. When the EA 2003 came into force on1 January 2004 the practice of drafting English charges continued, initially at least, in extradition hearings under the new Act in cases where the judicial authority was required to demonstrate dual criminality… However, my experience (and this was confirmed by counsel) is that the practice has substantially fallen out of use in recent times. 42. In my judgment it is time that the practice of drafting English charges was revived. Except in the most straightforward of cases, where the issuing judicial authority needs to demonstrate dual criminality for the purposes of sections 64 and 65 I consider that it is essential for the proper presentation of the prosecution’s case for charges to be drafted so as to specifically identify for the benefit of the District Judge and the Defendant the conduct in the EAW that is being relied upon, and what is said to be the equivalent English offence which would, in corresponding circumstances, be constituted by that offence. The use of English charges, whilst not having any formal status, results in precision as to the conduct for which extradition is, or is not, being requested, and produces certainty as to what conduct extradition is being ordered for.”
“… in my view, there is no restriction on the inherent jurisdiction of the High Court on appeal to admit further evidence from a respondent to an extradition appeal. It is open to a respondent to apply to this court to exercise its inherent jurisdiction and admit further evidence in support of an extradition decision of a district judge.”
“… Indeed, given that the court has the jurisdiction to request and admit such evidence, not to request and admit such evidence when the court considers it is in the interests of justice to do so would not only be contrary to the CrimPR, but a curious and perverse course for a court to take.”
“(1) A person’s extradition to a category 1 territory is barred by reason of absence of prosecution decision if (and only if)— (a) it appears to the appropriate judge that there are reasonable grounds for believing that— (i) the competent authorities in the category 1 territory have not made a decision to charge or have not made a decision to try (or have made neither of those decisions), and (ii) the person’s absence from the category 1 territory is not the sole reason for that failure, and (b) those representing the category 1 territory do not prove that— (i) the competent authorities in the category 1 territory have made a decision to charge and a decision to try, or (ii) in a case where one of those decisions has not been made (or neither of them has been made), the person’s absence from the category 1 territory is the sole reason for that failure. (2) In this section ‘to charge’ and ‘to try’, in relation to a person and an extradition offence, mean— (a) to charge the person with the offence in the category 1 territory, and (b) to try the person for the offence in the category 1 territory.” (a) it appears to the appropriate judge that there are reasonable grounds for believing that— (i) the competent authorities in the category 1 territory have not made a decision to charge or have not made a decision to try (or have made neither of those decisions), and (ii) the person’s absence from the category 1 territory is not the sole reason for that failure, and (b) those representing the category 1 territory do not prove that— (i) the competent authorities in the category 1 territory have made a decision to charge and a decision to try, or (ii) in a case where one of those decisions has not been made (or neither of them has been made), the person’s absence from the category 1 territory is the sole reason for that failure. (a) to charge the person with the offence in the category 1 territory, and (b) to try the person for the offence in the category 1 territory.”
“3. If a decision to charge or try has not been made, please can you confirm whether the requested person’s absence from the requesting state is the sole reason for this? If it is not the reason, please provide further details. … In the present case, Lynda THYER was informed of the investigation and summoned by the investigators on the instructions of the investigating judge. She did not appear before the judge despite her promise to do so. However, she assigned an advocate who stated that he was waiting for a EAW to be issued against his client Ms Thyer. The minutes attached in Appendix 1 confirm these elements. The voluntary absence of Ms Thyer justified the issue of an arrest warrant on March 02, 2017; the warrant furthermore states the grounds for this. The arrest warrant and its international dissemination appear to be the only means to search overseas for a person whose address is unknown and who, by refusing to appear when summoned, is deemed to be on the run.”
“(a) Sending a summons for Ms Thyer to attend a voluntary hearing as a suspect in France Ms Thyer had been served summons on instructions of the investigating judge and did not answer the court summons. (b) Using videoconferencing Videoconferencing is not an authorised method for a first appearance hearing before an investigating judge. (c) Travelling to the UK in order to speak to Ms Thyer A French judge cannot undertake a first appearance hearing on foreign soil. (b) Requesting that the UK authorities prosecute her in the UK for the offences allegedly committed in France All the offences attributed to Ms Thyer took place in France and many perpetrators are already charged. Only the appearance of all the perpetrators in a single trial will help determine the criminal liability of each of them and ensure an adversarial procedure for all parties.”
“20. Do you agree with the suggestion… that the EAW was issued in order to determine whether or not it would be appropriate to initiate proceedings against Ms Thyer? … The only reason she has not yet been charged is her refusal to respond to the summons served by French authorities. The ongoing investigation aims at confirming or overturn[ing] the charges brought against her and the declarations of Ms Thyer will be relevant to fulfil this objective.”
“40. I am satisfied there are reasonable grounds for believing that the RP’s absence from France is the sole reason for the failure to decide to try the RP. This is based on: (a) The evidence from both Mr Julié and the JA is that an essential procedural step in France is that the examining judge provides a person with the opportunity to be questioned prior to being charged. The information for the JA provides details of the investigation conducted and some of the evidence obtained. The investigation cannot proceed further without the examining judge questioning the RP. (b) The RP has to be questioned in France. (c) The RP was summoned to France but chose not to answer the summons. (d) The RP has not taken any steps to liaise with the French authorities to arrange her surrender or to speak to the examining judge. (e) I do not accept the evidence of Mr Julié that there are other ways that the examining judge could question the RP. (f) Mr Julié accepted that it was not clear if there was a joint investigation. Without that videoconferencing cannot be used. (g) I do not accept Mr Julié’s interpretation that because the Court of Appeal has allowed another examining judge to question a person, that means that the judge could travel to the UK to speak to the RP or ask the UK authorities to carry out that duty. The clear evidence of the JA is that the RP must be questioned by the examining judge in France. (h) In Puceviciene (above) it was made clear that mutual legal assistance and section 21B had no relevance to section 21A. In any event the RP has made no request to the French authorities under section 21B either for temporary transfer or to speak to the French authorities.”
“Where, as a matter of law, a decision to try a defendant could in theory be taken notwithstanding that they are absent from Category 1 territory, but the relevant authority in that territory states that they are not prepared to take that decision until the defendant has been questioned and they wish that questioning to take place in their home state, then the sole reason for the absence of a decision to try the defendant will be the defendant’s absence from the requesting Category 1 territory.”
“(a) the seriousness of the conduct alleged to constitute the extradition offence; (b) the likely penalty that would be imposed if [the RP] was found guilty of the extradition offence; (c) the possibility of the relevant foreign authorities taking measures that would be less coercive than the extradition of [the RP].”
“With regards to the prospect of extradition, I have grave concerns about how this would impact on her mental health and wellbeing. She is currently presenting as extremely fragile and emotionally unstable, and I am of the opinion a serious attempt of suicide cannot be ruled out”
“My mother had an accident approximately four years ago resulting in her impaired immobility. She lives in an adapted bungalow. She has been diagnosed with osteoporosis and osteoarthritis and has had her left knee replaced. She has had two knee operations and a fused muscle in her leg. My mother also suffers from high blood pressure. She has been assessed by physiotherapists who have advised her that she is unlikely to walk again. She often falls during the night and I have to be there to help her back into bed.”